Jean-Luc Cracowski|Françoise Stanke-Labesque|Germain Bessard - JoVE Visualize

Showing results (1-10 of 248) with videos related to

Pageof 25

Sort By:

British Journal of Pharmacology|September 12, 2003

Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated ratsFrançoise Stanke-Labesque, Gaëlle Hardy, Françoise Caron, et al.

Canadian Journal of Physiology and Pharmacology|July 29, 2005

Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive ratsStéphanie Marlière, Jean-Luc Cracowski, Ahmed Hakim, et al.

Prostaglandins & Other Lipid Mediators|November 24, 2005

Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometryGaëlle Hardy, Robert Boizel, Janine Bessard, et al.

Journal of Cardiovascular Pharmacology|June 27, 2003

Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veinsAhmed Hakim, Françoise Stanke-Labesque, Pascale Hoffmann, et al.

Arthritis and Rheumatism|July 13, 2002

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposureJean-Luc Cracowski, Patrick H Carpentier, Bernard Imbert, et al.

Therapie|November 7, 2007

[Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions]Johnny Moretto, Germain Bessard, Françoise Stanke-Labesque

Hypertension (Dallas, Tex. : 1979)|February 8, 2003

Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertensionJean-Luc Cracowski, Jean-Philippe Baguet, Olivier Ormezzano, et al.

Therapie|June 18, 2004

[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine]Germain Bessard, Gaëlle Hardy, Alain Chartier, et al.

Journal of Cardiovascular Pharmacology|February 28, 2002

Response of rat thoracic aorta to F(2)-isoprostane metabolitesJean-Luc Cracowski, Laetitia Camus, Thierry Durand, et al.

British Journal of Pharmacology|March 6, 2002

The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous veinStéphanie Marlière, Jean-Luc Cracowski, Thierry Durand, et al.

Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:

Pageof 25

British Journal of Pharmacology|September 12, 2003

Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated ratsFrançoise Stanke-Labesque, Gaëlle Hardy, Françoise Caron, et al.

Canadian Journal of Physiology and Pharmacology|July 29, 2005

Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive ratsStéphanie Marlière, Jean-Luc Cracowski, Ahmed Hakim, et al.

Prostaglandins & Other Lipid Mediators|November 24, 2005

Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometryGaëlle Hardy, Robert Boizel, Janine Bessard, et al.

Journal of Cardiovascular Pharmacology|June 27, 2003

Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veinsAhmed Hakim, Françoise Stanke-Labesque, Pascale Hoffmann, et al.

Arthritis and Rheumatism|July 13, 2002

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposureJean-Luc Cracowski, Patrick H Carpentier, Bernard Imbert, et al.

Therapie|November 7, 2007

[Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions]Johnny Moretto, Germain Bessard, Françoise Stanke-Labesque

Hypertension (Dallas, Tex. : 1979)|February 8, 2003

Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertensionJean-Luc Cracowski, Jean-Philippe Baguet, Olivier Ormezzano, et al.

Therapie|June 18, 2004

[Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine]Germain Bessard, Gaëlle Hardy, Alain Chartier, et al.

Journal of Cardiovascular Pharmacology|February 28, 2002

Response of rat thoracic aorta to F(2)-isoprostane metabolitesJean-Luc Cracowski, Laetitia Camus, Thierry Durand, et al.

British Journal of Pharmacology|March 6, 2002

The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous veinStéphanie Marlière, Jean-Luc Cracowski, Thierry Durand, et al.

Pageof 25